SWOG clinical trial number
SWOG-8605
Cyclosphosphamide, Ara-C Infusion and Vincristine for Relapsed or Refractory Extensive Small Cell Lung Cancer: A Phase II Study of The Southwest Oncology Group
Closed
Phase
Published
Abbreviated Title
Cyclosphosphamide, Ara-C Infusion and Vincristine for Relapsed or Refractory Extensive Small Cell Lung Cancer: A Phase II Study of The Southwest Oncology Group
Activated
08/29/1987
Closed
02/01/1989
Publication Information Expand/Collapse
1993
Predictors of survival following relapse or progression of small cell lung cancer: Southwest Oncology Group study #8605 and an analysis of the recurrent disease data base.